From Johns Hopkins: FDG PET/CT in the Management of Primary Pleural Tumors and Pleural Metastases

http://www.ncbi.nlm.nih.gov/pubmed/23883236

AJR Am J Roentgenol. 2013 Aug;201(2):W215-26. doi: 10.2214/AJR.13.10572.

FDG PET/CT in the Management of Primary Pleural Tumors and Pleural Metastases.

Kruse M, Sherry SJ, Paidpally V, Mercier G, Subramaniam RM.

Source

1 Russel H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, 601 N Caroline St / JHOC 3235, Baltimore, MD 21287.

Abstract

OBJECTIVE. FDG PET/CT is emerging as an important modality in the evaluation of pleural tumors. PET/CT has an established role in the diagnosis and staging and shows promise in therapy planning, therapy response assessment, and providing prognostic information in patients with malignant pleural mesothelioma. This modality has distinct advantages in characterizing other primary pleural tumors and pleural metastases. CONCLUSION. FDG PET/CT is a useful imaging modality in the management of patients with primary pleural tumors and pleural metastases.